Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Operating Cash Flow per Share : ¥0.01 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Operating Cash Flow per Share?

Hainan Huluwa Pharmaceutical Group Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥-0.46. Hainan Huluwa Pharmaceutical Group Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hainan Huluwa Pharmaceutical Group Co was -98.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 100.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Hainan Huluwa Pharmaceutical Group Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:605199' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -74.3 Med: 25.8 Max: 100
Current: 100

During the past 8 years, Hainan Huluwa Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 100.00% per year. The lowest was -74.30% per year. And the median was 25.80% per year.

SHSE:605199's 3-Year OCF Growth Rate is ranked better than
97.4% of 808 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs SHSE:605199: 100.00

Hainan Huluwa Pharmaceutical Group Co Operating Cash Flow per Share Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Operating Cash Flow per Share Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.40

0.01

0.26

0.59

0.07

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.29	-0.10	-0.23	0.80	-0.46

Competitive Comparison of Hainan Huluwa Pharmaceutical Group Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.

Hainan Huluwa Pharmaceutical Group Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Hainan Huluwa Pharmaceutical Group Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	28.252	/	394.436
	=	0.07

Hainan Huluwa Pharmaceutical Group Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-190.444	/	414.750
	=	-0.46

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.01

Hainan Huluwa Pharmaceutical Group Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines